Danzig M R, Ghandour R A, Chang P, Wagner A A, Pierorazio P M, Allaf M E, McKiernan J M
Urol Oncol. 2017 Mar;35(3):116. doi: 10.1016/j.urolonc.2016.05.011.
We compared renal function outcomes among patients in the surveillance and intervention arms of the DISSRM registry.
Patients were grouped into chronic kidney disease stages by estimated glomerular filtration rate range. Cases were considered up staged if a more advanced chronic kidney disease stage was entered during followup. Chronic kidney disease up staging-free survival was compared among groups using Kaplan-Meier analysis and paired comparisons log rank tests. Multivariate Cox regression identified independent predictors of chronic kidney disease up staging-free survival.
A total of 162 patients met the study inclusion criteria, with 68 in the surveillance arm, 65 undergoing partial nephrectomy, 15 undergoing radical nephrectomy, and 14 undergoing cryoablation. Median tumor size was 2.2cm. Mean estimated glomerular filtration rate change was significantly larger for radical nephrectomy vs. surveillance (-9.2 vs. -0.5ml/min/1.73m) and for radical vs. partial nephrectomy (-9.2 vs. -1.9ml/min/1.73m) (P = 0.001). No other groups differed significantly. On Kaplan-Meier analysis, patients undergoing radical nephrectomy had significantly worse chronic kidney disease up staging-free survival vs. those treated with partial nephrectomy (P = 0.029), surveillance (P = 0.007), and cryoablation (P = 0.019). No other groups differed significantly. On multivariate analysis, radical nephrectomy independently predicted poor chronic kidney disease up staging-free survival (odds ratio vs. surveillance 30.6, P = 0.001). Neither partial nephrectomy (P = 0.985) nor cryoablation (P = 0.976) predicted poor chronic kidney disease up staging-free survival relative to surveillance.
Patients in the surveillance arm had superior estimated glomerular filtration rate preservation compared to those in the radical nephrectomy but not the partial nephrectomy arm. In certain patients with small renal masses, surveillance and partial nephrectomy may offer comparable renal functional outcomes. This could be partly attributable to a modest estimated glomerular filtration rate decrease associated with surveillance itself. A thorough understanding of the renal functional impacts of treatment modalities is critical in the management of small renal masses.
我们比较了DISSRM注册研究中监测组和干预组患者的肾功能结局。
根据估计的肾小球滤过率范围将患者分为慢性肾脏病各期。如果在随访期间进入更晚期的慢性肾脏病阶段,则病例被视为分期进展。使用Kaplan-Meier分析和配对比较对数秩检验比较各组之间的无慢性肾脏病分期进展生存期。多变量Cox回归确定了无慢性肾脏病分期进展生存期的独立预测因素。
共有162例患者符合研究纳入标准,其中监测组68例,65例行部分肾切除术,15例行根治性肾切除术,14例行冷冻消融术。肿瘤中位大小为2.2cm。根治性肾切除术组与监测组相比,平均估计肾小球滤过率变化显著更大(-9.2对-0.5ml/min/1.73m²),根治性肾切除术组与部分肾切除术组相比也显著更大(-9.2对-1.9ml/min/1.73m²)(P = 0.001)。其他组之间无显著差异。根据Kaplan-Meier分析,根治性肾切除术患者的无慢性肾脏病分期进展生存期明显差于部分肾切除术(P = 0.029)、监测组(P = 0.007)和冷冻消融术组(P = 0.019)患者。其他组之间无显著差异。多变量分析显示,根治性肾切除术独立预测无慢性肾脏病分期进展生存期较差(与监测组相比,比值比为30.6,P = 0.001)。相对于监测组,部分肾切除术(P = 0.985)和冷冻消融术(P = 0.976)均未预测无慢性肾脏病分期进展生存期较差。
与根治性肾切除术组相比,监测组患者的估计肾小球滤过率保留情况更好,但与部分肾切除术组相比并非如此。在某些小肾肿瘤患者中,监测和部分肾切除术可能提供相当的肾功能结局。这可能部分归因于监测本身导致的估计肾小球滤过率适度下降。在小肾肿瘤的管理中,全面了解治疗方式对肾功能的影响至关重要。